Monitoring report · published · reflects the rules at that date

SCCS publishes final opinion on Hydroxyapatite (nano)

Our monitoring reports record the changes to cosmetics rules in a given period, and we publish one each month. Each one is a dated publication: it reflects the rules on the date it was published and is not updated afterwards. For what applies today, read the latest briefings or ask us.

See what happens after launch

On January 11, 2023, the EU Scientific Committee on Consumer Safety (SCCS) published the preliminary opinion SCCS/1648/22 on Hydroxyapatite (CAS No. 1306-06-17) in nano form. The opinion was open for comments until March 1, 2023. Considering the information received during the commenting period, the SCCS released its final opinion on March 23, 2023.

BACKGROUND

Hydroxyapatite is a mineral obtained from pearl oyster shells, salmon bones, phosphate rock, or derived synthetically. Hydroxyapatite is used in cosmetic products as abrasive, bulking, skin conditioning and oral care agent.

Article 2(1)(k) of EU Cosmetics Regulation (EC) No. 1223/2009 states that ‘nanomaterial’ means an insoluble or biopersistent and intentionally manufactured material with one or more external dimensions, or an internal structure, on the scale from 1 to 100 nm.

The nanomaterials definition covers materials in the nano-scale that are intentionally made and are insoluble/partially-soluble or biopersistent. It does not cover those that are soluble or degradable/non-persistent in biological systems.

Article 16 of the EU Cosmetics Regulation requires cosmetic products containing nanomaterials other than colourants, preservatives and UV-filters and not otherwise restricted by the Cosmetics Regulation to be notified to the European Commission six months prior to being placed on the market. If there are concerns over the safety of a notified nanomaterial, the European Commission shall refer it to the Scientific Committee on Consumer Safety (SCCS) for a full risk assessment.

WHAT’S NEW?

Based on the data submitted via the Cosmetic Products Notification Portal (CPNP), additional information provided by the industry, and other relevant information in scientific literature, the SCCS conducted a safety assessment on Hydroxyapatite (nano), and published its final opinion.

SCCS considers Hydroxyapatite (nano) as safe if used at concentrations up to 10% in toothpaste, and up to 0.465% in mouthwash. The opinion conclusions only apply to the substance with the following characteristics:

  1. Composed of rod-shaped particles of which at least 95.8% (in particle number) have an aspect ratio less than 3, and the remaining 4.2% have an aspect ratio not exceeding 4.9;
  2. The particles are not coated or surface modified.

References:

Scientific Committee on Consumer Safety (SCCS) – Final opinion on Hydroxyapatite (nano), SCCS/1648/22, March 23, 2023.

Need to know what this means for a product you have on the market now?

Ask the team for this area

One question works best. Leave out confidential product details; we can take those up by email.

Our team replies to every question. The reply goes to the email you gave.

We use your email to answer this question and for nothing else. Privacy and cookies

Follow an area

One email when an area publishes, in the language you choose. Nothing else.

Talk to us

Tell us the product, the market and the date you are working to. If the date is not realistic, we will say so.

Need a standing regulatory partner? See ongoing support →